⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for A Dose Confirmation and Pharmacokinetic Study of Pegcrisantaspase Administered as Intravenous (IV) Infusion in Children and Young Adults With Acute Lymphoblastic Leukemia (ALL) /Lymphoblastic Lymphoma (LBL). Following Hypersensitivity to Pegaspargase (Oncaspar)

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: A Dose Confirmation and Pharmacokinetic Study of Pegcrisantaspase Administered as Intravenous (IV) Infusion in Children and Young Adults With Acute Lymphoblastic Leukemia (ALL) /Lymphoblastic Lymphoma (LBL). Following Hypersensitivity to Pegaspargase (Oncaspar)

Official Title: A Dose Confirmation and Pharmacokinetic Study of Pegcrisantaspase Administered as Intravenous (IV) Infusion in Children and Young Adults With Acute Lymphoblastic Leukemia (ALL) /Lymphoblastic Lymphoma (LBL). Following Hypersensitivity to Pegaspargase (Oncaspar)

Study ID: NCT02257684

Interventions

pegcrisantaspase

Study Description

Brief Summary: The purpose of this study is to evaluate the effectiveness,safety, and dosage of pegcrisantaspase in patients with Acute Lymphoblastic Leukemia (ALL) / Lymphoblastic Lymphoma (LBL).

Detailed Description: The purpose of the study was to assess the response rate in children and young adults with ALL/LBL and hypersensitivity to pegaspargase defined as the proportion of subjects having a serum asparaginase activity (SAA) level of ≥ 0.1 IU/mL 14 days following the first IV pegcrisantaspase dose in Course 1. Also, to assess the safety of IV pegcrisantaspase therapy in children and young adults with ALL/LBL with hypersensitivity to pegaspargase.

Keywords

Eligibility

Minimum Age: 1 Year

Eligible Ages: CHILD, ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Phoenix Children's Hospital, Phoenix, Arizona, United States

Arkansas Children's Hospital, Little Rock, Arkansas, United States

Miller Children's Hospital, Long Beach, California, United States

Children's Hospital of Los Angeles, Los Angeles, California, United States

Children's Hospital Central California, Madera, California, United States

Kaiser Permanente, Oakland, California, United States

Children's Hospital of Orange County, Orange, California, United States

UCSF Benioff Children's Hospital / UCSF Benioff Children's Hospital, San Francisco, California, United States

Children's Hospital Colorado, Aurora, Colorado, United States

Children's National Medical Center Center for Cancer & Blood Disorders, Washington, District of Columbia, United States

Nemours Children's Clinic, Jacksonville, Florida, United States

All Children's Hospital, St. Petersburg, Florida, United States

Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States

Riley Hospital for Children / Indiana University, Indianapolis, Indiana, United States

Kosair Children's Hospital, Louisville, Kentucky, United States

Children's Hospital Main Campus, New Orleans, Louisiana, United States

Johns Hopkins University, Baltimore, Maryland, United States

C.S. Mott / University of Michigan, Ann Arbor, Michigan, United States

Wayne State University c/o Children's Hospital of Michigan, Detroit, Michigan, United States

University of Minnesota Medical Center - Fairview, Minneaplois, Minnesota, United States

Children's Hospitals & Clinics of Minnesota, Minneapolis, Minnesota, United States

University of Mississippi Medical Center, Jackson, Mississippi, United States

Children's Mercy Hospital - Kansas City, Kansas City, Missouri, United States

Washington University School of Medicine, St. Louis, Missouri, United States

Children's Hospital & Medical Center of Omaha, Omaha, Nebraska, United States

Hackensack University Medical Center, Hackensack, New Jersey, United States

Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States

The Steven and Alexandra Cohen Children's Medical Center of New York, New Hyde Park, New York, United States

University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States

Carolinas Medical Center, Levine Cancer Institute, Levine Children's Hospital, Charlotte, North Carolina, United States

Cincinnati Children's Hospital Medical, Cincinnati, Ohio, United States

Nationwide Children's Hospital, Columbus, Ohio, United States

The University of Oklahoma Health Sciences Center, Oklahoma, Oklahoma, United States

Penn State Children's Hospital, Hershey, Pennsylvania, United States

Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States

Bi-Lo Charities Children's Cancer Center, Greenville, South Carolina, United States

Vanderbilt University Ingram Cancer Center, Nashville, Tennessee, United States

Dell Children's Medical Center, Austin, Texas, United States

The University of Texas Southwestern Medical Center, Dallas, Texas, United States

Texas Children's Hospital / Baylor College of Medicine, Houston, Texas, United States

Seattle Children's Hospital, Seatlle, Washington, United States

University of Wisconsin / American Family Children's Hospital, Madison, Wisconsin, United States

Children's Hospital of Wisconsin / Midwest Children's Cancer Center, Milwaukee, Wisconsin, United States

Contact Details

Name: Roman Skowronski, MD, PhD

Affiliation: Jazz Pharmaceuticals

Role: STUDY_DIRECTOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: